A comparison of two invasive strategies in patients with non-ST elevation acute coronary syndromes: Results of the early or late intervention in unstable angina (ELISA) pilot study: 2b/3a upstream therapy and acute coronary syndromes

European Heart Journal

Volumn 24, Issue 15, 2003, Pages 1401-1405

  Van 't Hof, Arnoud W J ^a   De Vries, Suzanna T ^a   Dambrink, Jan Henk E ^a   Miedema, Kor ^a   Suryapranata, Harry ^a   Hoorntje, Jan C A ^a   Gosselink, A T Marcel ^a   Zijlstra, Felix ^a   De Boer, Menko Jan ^a  

^a ISALA HOSPITAL   (Netherlands)

Author keywords

Anti platelet therapy; Enzymatic infarct size; Non ST elevation ACS

Indexed keywords

CREATINE KINASE MB; FIBRINOGEN RECEPTOR ANTAGONIST; LACTATE DEHYDROGENASE; TIROFIBAN;

ADULT; AGED; ANGIOCARDIOGRAPHY; AREA UNDER THE CURVE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; ENZYME RELEASE; FEMALE; HEART INFARCTION SIZE; HUMAN; INTERMETHOD COMPARISON; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; NON ST SEGMENT ELEVATION ACUTE CORONARY SYNDROME; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; ST SEGMENT ELEVATION; TRANSLUMINAL CORONARY ANGIOPLASTY; UNSTABLE ANGINA PECTORIS;

ANGINA, UNSTABLE; CORONARY ANGIOGRAPHY; DEATH, SUDDEN, CARDIAC; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PILOT PROJECTS; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; RECURRENCE; TIME FACTORS; TREATMENT OUTCOME; TYROSINE;

EID: 0041903646     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0195-668X(03)00259-8     Document Type: Article

References (13)

1. Fragmin and fast Revascularization during Instability in Coronary artery disease Investigators. Invasive compared with non-invasive treatment in unstable coronary artery disease. Lancet 1999; 354:708-15.
2. Cannon CP, Weintraub WS, Demopoulos LA et al. The TACTICS - Thrombolysis in Myocardial Infarction 18 Investigators. Comparison of early invasive and Conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban N Engl J Med 2001;344:1879-87.
3. De Feyter PJ, Serruys PW. Percutaneous transluminal coronary angioplasty for unstable angina. In: Topol EJ, editor. Textbook of interventional cardiology, Vol 1. Philadelphia, PA: WB Saunders; 1993, p. 274-91.
4. White CJ, Ramee SR, Collins TJ et al. Coronary thrombi increase PTCA risk. Circulation 1996;93:253-8.
5. Van den Brand M, van Zijl A, Geuskens R et al. Tissue plasminogen activator in refractory unstable angina. A randomized controlled trial in patients with refractory unstable angina and subsequent angioplasty. Eur Heart J 1991;12:1208-14.
6. Topol EJ, Moliterno DJ, Herrmann HC et al. TARGET Investigators. Comparison of two platelet glycoprotein IIb/IIIa inhibitors, tirofiban and abciximab, for the prevention of ischemic events with percutaneous coronary revascularization. N Engl J Med 2001;344:1888-94.
7. Gibson CM, Cannon CP, Daley WL et al. TIMI frame count: a quantitative method of assessing coronary artery flow. Circulation 1996; 93:879-88.
8. Van der Laarse A, Hermens WT, Hollaar L et al. Assessment of myocardial damage in patients with acute myocardial infarction by serial measurement of serum alpha-hydroxybutyrate dehydrogenase levels. Am Heart J 1984;107:248-60.
9. Hermens WT, Willems GM, Nijssen KM et al. Effect of thrombolytic treatment delay on myocardial infarct size. Lancet 1992;340:1297 (letter).
10. de Boer MJ, Suryapranata H, Hoorntje JCA et al. Limitation of infarct size and preservation of left ventricular function after primary coronary angioplasty compared with intravenous streptokinase in acute myocardial infarction. Circulation 1994;90:753-61.
11. Januzzi JL, Hahn SS, Chae CU et al. Effects of tirofiban plus heparin versus heparin alone on troponin I levels in patients with acute coronary syndromes. Am J Cardiol 2000;86:713-7.
12. Neumann FJ. ISAR-COOL. Late Breaking Clinical Trial Session. American Heart Association Meeting, Chicago, November 2002.
13. Wallentin L, Lagerqvist B, Husted S et al. for the FRISC II Investigators. Outcome at 1 year after an invasive compared with a non-invasive strategy in unstable coronary-artery disease: the FRISC II invasive randomised trial. Lancet 2001;356:9-16.